Tag: PD-1 inhibitor for early melanoma

Home / PD-1 inhibitor for early melanoma

Categories

Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma

Nov 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Company) was granted approval by the Food and Drug Administration as an adjuvant therapy for Stage IIB/C melanoma in patients 12 years of age and ol...
pd-1-inhibitor-for-early-melanoma

Scan the code